Advertisement

Topics

Foamix Ltd Company Profile

20:20 EDT 24th June 2018 | BioPortfolio

Foamix Ltd. is a leading developer of topical and mucosal foams for dermatological and gynecological applications. Foamix's state-of-the-art foams provide controlled delivery of a variety of active ingredients. Foamix is currently collaborating with pharmaceutical and cosmetic companies on a range of projects in the development of proprietary dermatological and gynecologic foam products. Additionally, the Company has an in-house pipeline of dermatological and gynecological formulations in foam presentation. Foamix's psoriasis foam product licensed to Dr. Reddy's Laboratories and marketed by Promius Pharma under the trade mark Scytera(TM) was launched in the United States in early 2009.


News Articles [4 Associated News Articles listed on BioPortfolio]

Foamix Pharmaceuticals' (FOMX) CEO Dave Domzalski on Q1 2018 Results - Earnings Call Transcript

Foamix Pharmaceuticals Ltd FOMX Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300

SummaryFoamix Pharmaceuticals Ltd Foamix, formerly Foamix Ltd is a pharmaceutical company that develops and commercializes proprietary topical drugs for various dermatological therapies. The company's...

AKCA Faces FDA Panel Tomorrow, ALDR To Report Data In June, TCMD Riding High

Today's Daily Dose brings you news about Akcea's regulatory catalyst to watch out for on Wednesday, Alder's near-term catalysts; Aralez Pharma shutting up shop in the U.S.; Foamix's progress in phase ...

Foamix Pharmaceuticals Ltd FOMX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09032018] Prices from USD $250

SummaryFoamix Pharmaceuticals Ltd Foamix, formerly Foamix Ltd is a pharmaceutical company that develops and commercializes proprietary topical drugs for various dermatological therapies. The company's...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Foamix Ltd

Foamix Ltd. is a leading developer of topical and mucosal foams for dermatological and gynecological applications. Foamix's state-of-the-art foams provide controlled delivery of a variety of activ...

More Information about "Foamix Ltd" on BioPortfolio

We have published hundreds of Foamix Ltd news stories on BioPortfolio along with dozens of Foamix Ltd Clinical Trials and PubMed Articles about Foamix Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Foamix Ltd Companies in our database. You can also find out about relevant Foamix Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Psoriasis
Psoriasis is a common skin condition affecting 2-3% of the population of the United Kingdom, where the skins replacement process is sped taking 2-6 days instead of the usual 21 - 28 days for the replacement of skin cells. Patients experience an accumulat...


Corporate Database Quicklinks



Searches Linking to this Company Record